Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

RASEF Inhibitors

RASEF inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of RASEF (Ras and EF-hand domain containing), a member of the Ras superfamily of small GTPases. RASEF is unique in that it possesses both a Ras-like GTPase domain and an EF-hand calcium-binding domain, which allows it to integrate signals related to both small GTPase signaling and calcium ion concentrations within cells. Like other Ras-related proteins, RASEF functions as a molecular switch, toggling between an active GTP-bound state and an inactive GDP-bound state. This activity regulates various cellular processes, including intracellular trafficking, cytoskeletal dynamics, and vesicular transport. The EF-hand domains suggest that RASEF may also be responsive to calcium signaling, adding an additional layer of regulation to its role in cellular homeostasis. Inhibitors of RASEF typically act by blocking its ability to bind and hydrolyze GTP or by interfering with its interaction with calcium, effectively preventing the protein from fulfilling its regulatory functions.

The inhibition of RASEF can significantly impact cellular processes that rely on its dual regulatory roles in GTPase activity and calcium-mediated signaling. By preventing RASEF from functioning properly, these inhibitors interfere with key signaling pathways that control cytoskeletal organization, vesicle trafficking, and intracellular communication. Researchers use RASEF inhibitors to better understand the specific roles this protein plays in cellular dynamics and how its combined GTPase and calcium-binding properties influence intracellular signaling networks. These inhibitors provide insights into how RASEF integrates distinct signals to coordinate complex cellular responses, particularly in processes such as cell shape regulation, motility, and vesicle transport. By studying RASEF inhibitors, scientists can further elucidate the molecular mechanisms governing Ras family proteins and the impact of calcium-mediated regulation on their function, contributing to a broader understanding of cellular signaling and homeostasis.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Farnesyl thiosalicylic acid

162520-00-5sc-205322
sc-205322A
1 mg
5 mg
$61.00
$82.00
15
(1)

FTS disrupts the association of Ras with the cell membrane, thereby inhibiting its activity. This could downregulate signals promoting the expression of the Ras and EF-hand domain-containing protein.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$219.00
$634.00
5
(1)

Manumycin A inhibits farnesyltransferase, an enzyme involved in post-translational modification of Ras. This could prevent Ras activation and downstream signaling that might upregulate the protein.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

BAPTA-AM is a cell-permeable calcium chelator. By sequestering intracellular calcium, it may hinder calcium signaling and the functional activity of EF-hand domain-containing proteins.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, which is upstream of Ras. By inhibiting PI3K, this compound might suppress Ras activation and thus the expression of the protein.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an inhibitor of MEK, which is downstream of Ras. By inhibiting MEK, it might disrupt pathways that promote the expression of Ras and EF-hand domain-containing proteins.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib inhibits EGFR, which can activate Ras. By blocking EGFR, this compound might reduce Ras activation and subsequent protein expression.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Sorafenib inhibits Ras/Raf signaling. By blocking this pathway, it may reduce the expression of Ras and EF-hand domain-containing proteins.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

2-APB modulates intracellular calcium release. By affecting calcium levels, it might inhibit the functional activity of EF-hand domain-containing proteins.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, a downstream effector of Ras. Inhibition might disrupt signals promoting the expression of the protein.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin inhibits PI3K, affecting Ras signaling. By inhibiting this pathway, it might downregulate the protein's expression.